-
Basel, April 6, 2022 — Sandoz today announces the extension and expansion until January 31, 2025 of its strategic collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).Digital
-
More than 100,000 patients with heart failure in China are using our new AI-enabled platform, AI Nurse, to manage their condition and aim for better health.
DigitalReimagine MedicineCardiovascular DiseaseFuture of HealthcareAccess to Healthcare -
Basel, April 20, 2020 — Novartis announced today that it has completed the acquisition of Amblyotech, a US-based software startup, and will, in collaboration with Ubisoft and McGill University, pursue the development of the acquired digital technology for the treatment of amblyopia.InnovationEye CareDigital
-
Basel, June 24, 2020 — Novartis revealed the healthcare and pharma industry has emerged as a desired career destination for tech talent during the COVID-19 pandemic, in the Powerful Pairing research report launched today.Reimagine MedicineInnovationDigitalData Science
-
Researchers from industry and academia will leverage new chemistry to hit difficult drug targets.
Biomedical ResearchDigitalDiseasesDrug DiscoveryEmerging TechnologyNovartis Institutes for BioMedical Research -
Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.
DigitalDrug DiscoveryEmerging TechnologyInnovationScientific Research -
A Novartis team couriers an experimental treatment across Europe to a patient as transit grinds to a halt.
COVID-19DigitalClinical ResearchClinical TrialsClinical ScienceDrug Development -
Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.
DigitalInnovationLiving With DiseaseRespiratoryReimagine Medicine -
Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.
Chronic IllnessDigitalHeart Failure -
Investing in innovative treatments is vital to alleviate the suffering caused by multiple sclerosis (MS).
Access to HealthcareDigitalFuture of HealthcareNeuroscience -
Doyle describes the road to improving patient outcomes across Europe through the HARMONY Alliance.
CancerDigitalGlobal Health PartnershipsOncologyWomen in ScienceWorking at Novartis -
Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.
DigitalEthical BusinessMedicine Safety
Pagination
- 1
- 2
- 3
- › Next page